Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions.
about
Modified extrusion-spheronization as a technique of microencapsulation for stabilization of choline bitartrate using hydrogenated soya bean oil.Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling.Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.Supercritical fluid technology: a promising approach in pharmaceutical research.Hot-melt extrusion--basic principles and pharmaceutical applications.Artemether-Soluplus Hot-Melt Extrudate Solid Dispersion Systems for Solubility and Dissolution Rate Enhancement with Amorphous State Characteristics.Influence of pressurized carbon dioxide on ketoprofen-incorporated hot-melt extruded low molecular weight hydroxypropylcellulosePreparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers.Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods.Hot melt extruded amorphous solid dispersion of posaconazole with improved bioavailability: investigating drug-polymer miscibility with advanced characterisation.Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology.Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory.A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction
P2860
Q35872797-30735197-95E9-4E80-9BA2-4981E55C3039Q36636489-9597443D-B67C-4C80-BBF7-4804F97C5965Q37896655-E66DAA99-702A-4EAA-B896-873D61326156Q38049372-504ED84A-364C-4130-A5DA-0E21D0B01A9FQ38187427-D7E32AD1-F2CF-4606-9FAE-DAD0FB5FDC54Q40335976-125AF3E8-50C1-4BB4-A44E-9CD52842E3D5Q41132134-B1949E1A-2BC5-4145-9E25-1F65E23AFE0EQ41132514-DEA9F567-549C-4CE0-9A28-054A4B3CBF99Q41870210-169CB51A-D624-497E-8956-F0A26EE5279AQ42114941-9468E76F-E115-405D-91B2-1886232D9387Q42383199-C1AB39C2-7962-4CB2-9F8D-3D267940EE78Q48244592-11C4EB94-006D-4CBF-9286-0E78ABD78C8BQ54342599-C6383D1D-702A-45D8-A083-EAA6C35DE340Q57164849-E43B0983-C5F5-48FF-B778-AE8E023B7000
P2860
Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Physicochemical characterizati ...... melt extruded glass solutions.
@en
Physicochemical characterizati ...... melt extruded glass solutions.
@nl
type
label
Physicochemical characterizati ...... melt extruded glass solutions.
@en
Physicochemical characterizati ...... melt extruded glass solutions.
@nl
prefLabel
Physicochemical characterizati ...... melt extruded glass solutions.
@en
Physicochemical characterizati ...... melt extruded glass solutions.
@nl
P2093
P2860
P1476
Physicochemical characterizati ...... melt extruded glass solutions.
@en
P2093
David S Jones
Febe Kusmanto
Gavin P Andrews
Osama Abu-Diak
Peter Hornsby
P2860
P304
P356
10.1111/J.2042-7158.2010.01177.X
P577
2010-11-01T00:00:00Z